Cetrimonium: Clinical Trials

3 trials of Cetrimonium, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 unknown. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Active not recruiting 1, Completed 1, Unknown 1

Follow Cetrimonium: new trials by email Literature Review of Cetrimonium trials Research Report on Cetrimonium

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ulcer Plants: Highly Accessible Plant Antiseptics for Use in Remote Areas of PNG - Second Trial
Ficus septica exudate, Active Comparator: Savlon antiseptic cream (cetrimide with chlorhexidine digluconate) - Cutaneous Ulcer Disease, Skin Sores
Phase 2Active not recruitingFundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia2222025-11-032026-07-16
Ulcer Plants: Highly Accessible Plant Antiseptics for Use in Remote Areas of PNG
Ficus septica exudate (antiseptic plant exudates), Pterocarpus indicus exudate, Curcuma longa aqueous extract - Cutaneous Ulcer Disease, Skin Sores
Phase 2CompletedFundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia3702024-10-042024-11-29
Single-centre Study to Investigate Safety and Efficacy of Tri-Solfen in Wound Debridement
Tri-Solfen Gel (Lidocaine HCl, Bupivacaine HCl, Adrenaline Acid Tartrate /Cetrimide), EMLA cream, Post Operative Analgesia (Paracetamol, Ibuprofen) - Wounds Injuries, Anesthesia, Local
Phase 2UnknownMedical Ethics UK Ltd902019-01-152019-03-06

Conditions studied

Lymphoproliferative Disorders (2)  ·  Skin Ulcer (2)  ·  Wounds and Injuries (1)

Sponsors

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia (2)  ·  Medical Ethics UK Ltd (1)

Countries

Papua New Guinea (2)  ·  United Kingdom (1)

Top investigators

Keith Harding (1)

NIH funding

2018 (1)